Dr Ola Landgren at ASH 2014: Therapeutic monoclonal antibodies in myeloma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Ola Landgren (Memorial Sloane Kettering Cancer Center, New York, NY) discusses the development of therapies with novel monoclonal antibodies in multiple myeloma, including antibodies that target CD38, CS1 and PD-1.

Year of Production:
Running Time:
Color/Sound:

2015
02:35
Color/Sound

Comments are closed.